Amends GS 90-106(a3) (limiting prescriptions of targeted controlled substances for pain) to limit the supply of targeted controlled substances a physician may prescribe to a patient after an initial consultation for acute pain to a three-day (was, five-day) supply. Effective October 1, 2021.
Bill Summaries: H793 (2021)
Tracking:
-
Bill H 793 (2021-2022)Summary date: May 3 2021 - View summary